Zomedica (ZOM) News and press releases

Zomedica (AMEX: ZOM) reported quarterly losses of $(0.007) per share. The company reported quarterly sales of $5.48 million which missed the analyst consensus estimate of $6.63 million by 17.32 percent. This is a 46.15 percent increase over sales of $3.75 million the same period last year.

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its first quarter.

Zomedica Pharmaceuticals (AMEX:ZOM) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.01) by 40 percent. The company reported quarterly sales of $6.16 million which missed

Zomedica Pharmaceuticals (AMEX:ZOM) reported quarterly sales of $6.20 million which met the analyst consensus estimate. This is a 51.92 percent increase over sales of $4.08 million the same period last year.

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.

ANN ARBOR, Ml / ACCESSWIRE / May 12, 2023 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals,

ANN ARBOR, MI / ACCESSWIRE / May 11, 2023 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for

ANN ARBOR, Ml / ACCESSWIRE / May 8, 2023 / Zomedica Corp. (NYSE:ZOM) ('Zomedica' or the 'Company'), today announced it has exercised its option to move forward with the acquisition of Structured Monitoring Products, Inc.

ANN ARBOR, MI / ACCESSWIRE / May 2, 2023 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, will

ANN ARBOR, MI / ACCESSWIRE / April 18, 2023 / Zomedica Corp. (NYSE:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced today that Larry Heaton,

ORLANDO, FL / ACCESSWIRE / March 31, 2023 / RedChip Companies will air a new interview with Zomedica Corp. (NYSE:ZOM) on The RedChip Money Report® on Bloomberg TV, this Saturday, April 1, at 7 p.m. Eastern Time

ANN ARBOR, MI / ACCESSWIRE / March 17, 2023 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for

ANN ARBOR, MI / ACCESSWIRE / March 15, 2023 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for

ANN ARBOR, MI / ACCESSWIRE / March 8, 2023 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals,